Quico, Jufiel D.

HRN: 21-40-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
CEFUROXIME 500MG (TAB)
05/23/2022
05/30/2022
ORAL
500mg
Q12
UTI
Waiting Final Action 
05/24/2022
CEFUROXIME 1.5GM (VIAL)
05/24/2022
05/31/2022
IVT
1.5g
Q8H
UTI, Complicated; Threatened Labor
Waiting Final Action 
05/26/2022
DOXYCYCLINE 100MG (CAP)
05/26/2022
06/02/2022
IV
100 Mg
Q12
Post OP (Exploratory Laparotomy For Tubal Pregnancy; S/p Salpingectomy)
Waiting Final Action 
05/27/2022
CEFUROXIME 500MG (TAB)
05/27/2022
06/02/2022
ORAL
500mg
BID
S/P Left Salpingectomy
Waiting Final Action 
10/26/2022
CEFUROXIME 1.5GM (VIAL)
10/26/2022
11/01/2022
IVTT
1.5g
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action 
10/27/2022
AZITHROMYCIN 500MG TABLET (TAB)
10/27/2022
10/31/2022
PER OREM
500mg
OD
Pulmonary Infection/ Infiltrates
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: